FindTrial
Sign In

Exploratory Study on Modifiers of the Effect of Nalmefene in Reducing Alcohol Consumption in Patients with Alcoholism on the Basis of Genetic Factors

Exploratory Study on Modifiers of the Effect of Nalmefene in Reducing Alcohol Consumption in Patients with Alcoholism on the Basis of Genetic Factors - Exploratory Study on Modifiers of the Effect of Nalmefene in Reducing Alcohol Consumption on the Basis of Genetic Factors

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000044990
Enrollment
540
Registered
2021-08-01
Start date
2021-06-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alcoholism

Interventions

None listed

Sponsors

Okayama University Hospital
Lead Sponsor
Otsuka Pharmaceutical Co., Ltd
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects who participated in the phase 3 study of the following clinical study and provide consent to the retention of their DNA: A multicenter, randomized, double-blind, placebo-controlled,3-parallel-group study(339-14-001) to verify the effect of nalmefene in reducing alcohol consumption in patients with alcoholism. Subjects who has a drug efficacy data on 12-week time point.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Information on genetic polymorphisms—

Countries

Japan

Contacts

Public ContactIzuru Nakamura

Otsuka Pharmaceutical Co., Ltd Medical Affairs

Nakamura.Izuru@otsuka.jp03-6717-1400

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026